Grade 2 Meningioma — Trials

Grade 2 Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

30 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–11 of 11 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02847559	Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma	completed	Phase 2	20	Northwestern UniversityOTHER	1	Sep 9, 2026	clinicaltrials
NCT03604978	Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma	active not recruiting	Phase 1 / Phase 2	38	National Cancer Institute (NCI)NIH	1	Jul 31, 2026	clinicaltrials
NCT04082520	Lutathera for the Treatment of Inoperable, Progressive Meningioma After External Beam Radiation Therapy	recruiting	Phase 2	42	Mayo ClinicOTHER	1	Apr 22, 2026	clinicaltrials
NCT04659811

Data updated 20 days agoSource updated Sep 9, 2026source: clinicaltrials